PLUR

Pluri Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$1.09

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %89.2 / %30

Non-compliant assets / Total market cap %28.8 / %30

Non-compliant revenue / Total income %45.1 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and an immunotherapy platform.

Website

Analysis (Turkish): PLUR Hissesi Caiz mi, Helal mi? Pluri Inc. Katılım Analizi